Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul>
<li>Gaxos.AI is comprised of two main startups: RNK Health and Gaxos Labs.</li>
<li>The large majority of revenues comes from RNK Health, a majority-owned subsidiary that markets wellness products online.</li>
<li>It advertises and markets products, primarily peptides such as NAD+ (which is the vast majority of sales), Sermorelin, and Glucagon-Like Peptides (GLP-1s) on its website and orders are fulfilled through its fulfillment partners.</li>
</ul>


Gaxos.AI is comprised of two main startups: RNK Health and Gaxos Labs.
The large majority of revenues comes from RNK Health, a majority-owned subsidiary that markets wellness products online.
It advertises and markets products, primarily peptides such as NAD+ (which is the vast majority of sales), Sermorelin, and Glucagon-Like Peptides (GLP-1s) on its website and orders are fulfilled through its fulfillment partners.


GXAI: Gaxos.AI, 2025년 실적 발표에서 예상치 상회하며 전망치 상향 조정

Gaxos.ai

GXAI: Gaxos.AI, 2025년 실적 발표에서 예상치 상회하며 전망치 상향 조정